Just Medical
Just Medical is an artificial orthopedic implant device and system developer
About Just Medical
Andon Health, publicly traded as Tianjin Jiuan Medical Electronics Co., Ltd. (002432.SZ), was established in 1995 by Liu Yi. An alumnus of Tianjin University with dual degrees in analytical instruments and industrial management, Liu identified an opportunity in the nascent market for electronic blood pressure monitors after a discussion with classmates. This led to the creation of the company's first device, laying the groundwork for its future in the medical device industry. The founder's journey began with a role as a technician before moving into the medical device sector, where he recognized a heavy reliance on foreign technology in the domestic market, sparking his entrepreneurial drive.
The company's history is marked by strategic international expansion, which commenced in 2002. A significant achievement came in 2006 when its voice-enabled blood pressure monitor successfully penetrated the German market, propelling the company's export volume into the global top three. A pivotal moment occurred in 2010 when Andon Health went public on the Shenzhen Stock Exchange and began a strategic transformation towards mobile health. This shift led to the creation of the iHealth brand in Silicon Valley in 2011 and the launch of the first mobile-connected blood pressure monitor compatible with Apple's iPhone, a move that received strong support from Apple. Further solidifying its position in the mobile health ecosystem, the company received a $25 million strategic investment from Xiaomi in 2014, becoming a partner in the Xiaomi ecological chain.
Andon Health operates in the global home-use medical device, in-vitro diagnostics (IVD), and internet health sectors. Its revenue model is driven by the sale of hardware products under its two main brands, "Andon" and "iHealth," as well as ODM/OEM services. A dramatic surge in revenue and profitability occurred with the immense success of its iHealth COVID-19 antigen home test kits in the United States, which received FDA Emergency Use Authorization (EUA) in November 2021. This positioned the company as a key supplier to the U.S. market during the pandemic. Beyond this, the company pursues two core strategies: developing "hit products" like its connected thermometers and blood pressure monitors, and implementing an "Offline+Online" (O+O) model for diabetes care. This O+O model integrates in-person hospital care with online, continuous management, creating a comprehensive service loop for chronic disease patients in both China and the US.
The company's product portfolio is extensive, covering personal health management through a system of "smart hardware + mobile applications + cloud services". The iHealth line includes a wide array of devices for monitoring blood pressure, blood glucose, body temperature, blood oxygen, and ECG, among other vitals. These devices connect to proprietary mobile apps, allowing users to track, manage, and share their health data. A key selling point is the integration of these devices into a comprehensive ecosystem, exemplified by the diabetes management platform that connects patients with a multidisciplinary care team. The success of its COVID-19 test kit was due to its accessibility as an over-the-counter product and its ability to deliver results in 15 minutes.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Open positions
- None listed
- Dealroom signal
- 17.0/100
- Industry
- Health
- Sector
- Diabetes, Health Diagnostics, Hard Tech, remote health monitoring
- Client focus
- B2B
- Links
- Website
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | May 2021 | $30M | $121M | Qiming Venture Partners | — |
| SERIES A✓Equity / VC | Aug 2019 | — | — | LYFE Capital · Yuansheng BioVenture | — |
Growth signals
Latest recorded traffic for Just Medical is 1.5K monthly website visits, up 1053.8% over the last three months.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Just Medical in its local ecosystem
The Just Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
Yuansheng BioVenture
LYFE Capital
Qiming Venture Partners
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Just Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Just Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









